Breast cancer molecular subtypes are defined by the expression of hormone receptors such as estrogen receptors (ER+) or progesterone receptors (PR+), human epidermal receptor 2 (HER2+), and triple-negative breast cancer (TNBC; which is ER−, PR−, HER2−). The gene discussed is PGR; the disease is triple-negative breast carcinoma.